

HY-164468 · 50 mg
MedChemExpress · Cat: HY-164468
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ch282-5.html
Description
Ch282-5 is an orally active inhibitor targeting the Bcl-2 protein, inducing mitochondria-dependent apoptosis Apoptosis by disrupting mitophagy and the mTOR pathway. Ch282-5 exhibits antiproliferative activity against colorectal cancer cells both in vitro and in vivo, and it also inhibits metastasis. Additionally, Ch282-5 enhances Oxaliplatin HY-17371 -induced autophagy Autophagy by downregulating the Mcl-1 protein and increasing platelet count, alleviating adverse effects of Navitoclax HY-10087 .







